Mitobridge Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mitobridge Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11307
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mitobridge Inc (Mitobridge), formerly Mitokyne Inc, a subsidiary of Astellas Pharma Inc is a drug development company that discovers and develops small molecule therapeutics that recovers mitochondrial functions. The company develops therapies for rare diseases and expands into more common diseases. Mitobridge utilizes screening platform to identify and develop novel therapeutics. The company holds expertise in the areas of mitochondrial genetic diseases, musculoskeletal, liver disease, kidney, neurodegenerative disorders and diseases and conditions of aging. It works in collaboration with companies in the field of mitochondrial biology and medicine. Mitobridge is headquartered in Cambridge, Massachusetts, the US.

Mitobridge Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mitobridge Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mitobridge Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mitobridge Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mitobridge Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mitobridge Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mitobridge Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Mitokyne Raises US$45 Million In Series A Financing 10
Partnerships 11
Astellas Pharma Enters Into R&D Agreement With Mitokyne For Drug Discovery 11
Licensing Agreements 12
Mitobridge Enters into Licensing Agreement with Ecole Polytechnique Federale de Lausanne 12
Mitobridge Enters into Licensing Agreement with Salk Institute for Biological Studies 13
Acquisition 14
Astellas Pharma Acquires Mitobridge 14
Mitobridge Inc – Key Competitors 15
Mitobridge Inc – Key Employees 16
Mitobridge Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Clinical Trials 18
Nov 06, 2017: Mitobridge Presents Preclinical Data Demonstrating Beneficial Effects of PPARd Modulators in Acute Kidney Injury at American Society of Nephrology Annual Meeting 18
Aug 08, 2017: Mitobridge’s Novel Treatment Approach for Duchenne Muscular Dystrophy Advances into Clinical Development 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Mitobridge Inc, Pharmaceuticals & Healthcare, Key Facts 2
Mitobridge Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mitobridge Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mitobridge Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mitobridge Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Mitobridge Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mitokyne Raises US$45 Million In Series A Financing 10
Astellas Pharma Enters Into R&D Agreement With Mitokyne For Drug Discovery 11
Mitobridge Enters into Licensing Agreement with Ecole Polytechnique Federale de Lausanne 12
Mitobridge Enters into Licensing Agreement with Salk Institute for Biological Studies 13
Astellas Pharma Acquires Mitobridge 14
Mitobridge Inc, Key Competitors 15
Mitobridge Inc, Key Employees 16

List of Figures
Mitobridge Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mitobridge Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mitobridge Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mitobridge Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mitobridge Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mitobridge Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mitobridge Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mitobridge Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Mitobridge Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Neste Corp (NESTE):石油・ガス:M&Aディール及び事業提携情報
    Summary Neste Corp (Neste) is an oil refining and marketing company that offers advanced, clean traffic fuels besides shipping and engineering services. The company produces and sells gasoline; diesel fuel; aviation fuel; bunker fuel; heating oil; light and heavy fuel oil; base oils; gasoline compon …
  • Central Japan Railway Co (9022):企業の財務・戦略的SWOT分析
    Central Japan Railway Co (9022) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • SVB Financial Group:企業のM&A・事業提携・投資動向
    SVB Financial Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SVB Financial Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Goodrich Petroleum Corp (GDP):石油・ガス:M&Aディール及び事業提携情報
    Summary Goodrich Petroleum Corp (Goodrich) is an independent oil and gas company. It explores, develops and produces oil and natural gas from properties that include Tuscaloosa Marine Shale in Eastern Louisiana and Southwestern Mississippi, Haynesville Shale trend in north Louisiana and east Texas, …
  • Maersk Tankers AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Maersk Tankers AS (Maersk Tankers), a subsidiary of A.P. Moeller Holding AS is an oil and gas company that offers energy transportation services through oil tankers. The company provides services such as crude oil and refined oil transportation, warehousing and distribution, supply chain man …
  • Samsung Electronics Co., Ltd.:企業の戦略・SWOT・財務情報
    Samsung Electronics Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samsung Electronics Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Neurocrine Biosciences Inc (NBIX):製薬・医療:M&Aディール及び事業提携情報
    Summary Neurocrine Biosciences Inc (Neurocrine) discovers, develops and commercializes pharmaceutical products for the treatment of neurologic, psychiatric and endocrine related diseases and disorders. Its lead product, Ingrezza (valbenazine) capsule is a US FDA approved selective vesicular monoamin …
  • TenneT Holding BV:電力:M&Aディール及び事業提携情報
    Summary TenneT Holding BV (TenneT), owned by the Ministry of Finance of The State of the Netherlands, is an electricity transmission system operator. The company offers electricity transmission and system services. It constructs and maintains high voltage grid to transmit electricity from the produc …
  • P.T. Telekomunikasi Selular:企業の戦略・SWOT・財務情報
    P.T. Telekomunikasi Selular - Strategy, SWOT and Corporate Finance Report Summary P.T. Telekomunikasi Selular - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cancom SE (COK):企業の財務・戦略的SWOT分析
    Cancom SE (COK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Cowen Inc:企業の戦略・SWOT・財務情報
    Cowen Inc - Strategy, SWOT and Corporate Finance Report Summary Cowen Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Maersk Line AS:企業の戦略的SWOT分析
    Maersk Line AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Acceleron Pharma Inc (XLRN):企業の財務・戦略的SWOT分析
    Acceleron Pharma Inc (XLRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Oxford Nanopore Technologies Ltd:企業の戦略的SWOT分析
    Oxford Nanopore Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Molnlycke Health Care AB:企業の戦略的SWOT分析
    Molnlycke Health Care AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Xactware Solutions Inc:企業の戦略的SWOT分析
    Xactware Solutions Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Anika Therapeutics Inc (ANIK):企業の製品パイプライン分析2018
    Summary Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regene …
  • Noevir Holdings Co Ltd (4928):企業の財務・戦略的SWOT分析
    Noevir Holdings Co Ltd (4928) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Cherkizovo Group OJSC (GCHE):企業の財務・戦略的SWOT分析
    Cherkizovo Group OJSC (GCHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆